Capecitabine-induced multifocal leukoencephalopathy: A report of five cases

A. Videnovic, I. Semenov, R. Chua-Adajar, L. Baddi, D. T. Blumenthal, A. C. Beck, Tatyana Simuni, Stephen F Futterer, William J Gradishar, C. Tellez, Jeffrey J Raizer*

*Corresponding author for this work

Research output: Contribution to journalArticle

56 Scopus citations

Abstract

Capecitabine is used to treat advanced breast and gastrointestinal malignancies. A single case of encephalopathy and three cases of peripheral neuropathy are the only neurotoxicities reported. The authors report five additional cases of capecitabine-induced multifocal leukoencephalopathy.

Original languageEnglish (US)
Pages (from-to)1792-1794
Number of pages3
JournalNeurology
Volume65
Issue number11
DOIs
StatePublished - Dec 1 2005

ASJC Scopus subject areas

  • Clinical Neurology

Fingerprint Dive into the research topics of 'Capecitabine-induced multifocal leukoencephalopathy: A report of five cases'. Together they form a unique fingerprint.

  • Cite this

    Videnovic, A., Semenov, I., Chua-Adajar, R., Baddi, L., Blumenthal, D. T., Beck, A. C., Simuni, T., Futterer, S. F., Gradishar, W. J., Tellez, C., & Raizer, J. J. (2005). Capecitabine-induced multifocal leukoencephalopathy: A report of five cases. Neurology, 65(11), 1792-1794. https://doi.org/10.1212/01.wnl.0000187313.83515.7e